Pharmacy

CMS issued a proposed rule Nov. 26 that includes changes to Medicare Advantage and Part D.

Amid shrinking reimbursements and rising care costs, hospital and health system leaders find themselves in a financial bind. The pressure is on executives to cut costs in order to maintain their organization's fiscal health.  

Amazon, which purchased PillPack earlier this year, may soon allow its employees to test out the pharmacy startup's services, CNBC reports.

Mylan will recall at least 15 lots of medications containing valsartan in the U.S. after the drug was found to contain a cancer-causing impurity, according to Reuters. This is the latest recall of valsartan amid heightened safety concerns about the…

Sun Pharma plans to combine its two manufacturing plants in New Jersey, placing 96 jobs at risk, according to ROI-NJ.

In the midst of the opioid epidemic, more pharmacists are receiving naloxone training to teach their customers how to use the overdose reversal treatment, according to STAT.

Becker's Hospital Review has reported the following five drug company layoffs in the last month. They are listed below, beginning with the most recent.

In the last year, Swiss pharma giant Novartis has spent nearly $15 billion on acquisitions that are pivoting the company toward treatments that bear little resemblance to traditional drugs, according to The Wall Street Journal.

After pressure from stakeholders, AstraZeneca has started looking for candidates to replace CEO Pascal Soriot, who has served at the helm of the drug company for six years, according to The (UK) Times.

Whether its Amazon's entry into the pharmacy space or changes with the 340B Drug Discount Program, it's no secret that the pharmacy sector is evolving.